147 related articles for article (PubMed ID: 6434233)
21. [Overcoming the radioresistance of tumor hypoxia as a fundamental prerequisite of neutron therapy].
Iarmonenko SP
Med Radiol (Mosk); 1977 Oct; 22(10):43-6. PubMed ID: 916838
[No Abstract] [Full Text] [Related]
22. [Clinical and radiobiologic evaluation of radiation dosage in radiotherapy of vaginal cancer].
Kanaev SV; Turkevich VG
Vopr Onkol; 1996; 42(6):44-7. PubMed ID: 9123901
[TBL] [Abstract][Full Text] [Related]
23. [Possibilities of development of complications of radiation therapy in patients with malignant tumors].
Pavlov AS; Datsenko VS; Fadeeva MA; Zamiatin OA
Med Radiol (Mosk); 1980 Apr; 25(4):8-13. PubMed ID: 7382766
[No Abstract] [Full Text] [Related]
24. Cell kinetics.
Wilson GD
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):370-84. PubMed ID: 17399964
[TBL] [Abstract][Full Text] [Related]
25. [Proliferation rate and radiosensitivity: were Bergonié and Tribondeau wrong?].
Streffer C
Strahlenther Onkol; 1997 Sep; 173(9):484. PubMed ID: 9340839
[No Abstract] [Full Text] [Related]
26. [Necessity of isolating critical cell populations that determine the effectiveness of radiation therapy].
Iarmonenko SP
Med Radiol (Mosk); 1978 Jan; 23(1):6-8. PubMed ID: 625217
[No Abstract] [Full Text] [Related]
27. [Comments on the review entitled "Radiobiological features of anticancer treatments involving synchrotron radiation: outcome and perspectives"].
Elleaume H; Rousseau J; Adam JF; Estève F
Cancer Radiother; 2011 Apr; 15(2):161-4; author reply 164-7. PubMed ID: 21146436
[No Abstract] [Full Text] [Related]
28. The response of tumours with Gompertzian growth characteristics to fractionated radiotherapy.
O'Donoghue JA
Int J Radiat Biol; 1997 Sep; 72(3):325-39. PubMed ID: 9298113
[TBL] [Abstract][Full Text] [Related]
29. Exposure to low dose ionising radiation: molecular and clinical consequences.
Martin LM; Marples B; Lynch TH; Hollywood D; Marignol L
Cancer Lett; 2013 Sep; 338(2):209-18. PubMed ID: 23693079
[TBL] [Abstract][Full Text] [Related]
30. The eighteenth Douglas Lea lecture. 40 years of radiobiology: its impact on radiotherapy.
Fowler JF
Phys Med Biol; 1984 Feb; 29(2):97-113. PubMed ID: 6422482
[TBL] [Abstract][Full Text] [Related]
31. Biologic basis for altered fractionation schemes.
Withers HR
Cancer; 1985 May; 55(9 Suppl):2086-95. PubMed ID: 3919923
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of radiation injuries during multifractionation in radiation therapy].
Zholkiver KI; Zevrieva IF
Med Radiol (Mosk); 1983 Apr; 28(4):3-6. PubMed ID: 6835069
[TBL] [Abstract][Full Text] [Related]
33. Normal tissue tolerance and damage.
Cancer; 1976 Apr; 37(4 Suppl):2046-55. PubMed ID: 1260701
[No Abstract] [Full Text] [Related]
34. The use of ATP bioluminescence assay and flow cytometry in predicting radiosensitivity of uterine cancer cell lines: correlation of radiotoxicity and cell cycle kinetics.
Nguyen HN; Sevin BU; Averette HE; Gottlieb CF; Perras J; Ramos R; Donato D; Penalver M
Gynecol Oncol; 1992 Jul; 46(1):88-96. PubMed ID: 1634145
[TBL] [Abstract][Full Text] [Related]
35. [Proliferation rate and radiosensitivity. Bergonié's and Tribondeau's error].
Beck-Bornholdt HP; Dubben HH; Willers H
Strahlenther Onkol; 1997 Jun; 173(6):335-7. PubMed ID: 9235641
[TBL] [Abstract][Full Text] [Related]
36. The clinical and biologic basis for radiation therapy of cutaneous carcinoma, melanoma, and lymphoma.
Massullo V
Adv Dermatol; 1995; 10():201-42; discussion 243. PubMed ID: 7794672
[No Abstract] [Full Text] [Related]
37. Clinical radiation pathology as applied to curative radiotherapy.
Rubin P; Casarett GW
Cancer; 1968 Oct; 22(4):767-78. PubMed ID: 5212301
[TBL] [Abstract][Full Text] [Related]
38. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
39. Radiation biology and treatment options in radiation oncology.
Withers HR
Cancer Res; 1999 Apr; 59(7 Suppl):1676s-1684s. PubMed ID: 10197580
[No Abstract] [Full Text] [Related]
40. [Radiobiological features of anti-cancer treatments involving synchrotron radiation: outcome and perspectives].
Foray N
Cancer Radiother; 2010 Apr; 14(2):145-54. PubMed ID: 20189428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
